Brighthouse Financial
BHFNASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $44.40 Prior regular-session close from the quote source.
- $43.98–$45.78 Regular-session low and high so far today.
- 660.5K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Feb 22 projected Projected for 2027-02-22 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $41.01–$66.80 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own BHF if the 2024–25 improvement in earnings and cash proves durable rather than one-off.
BHF price history
Loading recent earnings…
Investment thesis
What must happen next
Improved liability management and capital-recycling actions will convert Brighthouse’s reported profits into sustainable positive operating cash flow, enabling recurring shareholder distributions.HoldingMateriality: High
NetCashProvidedByUsedInOperatingActivities = 259000000.0 (annual, period_end 2025) — turned positive in 2025 after prior negatives. If true, owners get a growing, reliable cash return (buybacks/dividends) and valuation expansion; if false, profits may not convert to distributable cash and the stock will be vulnerable to re-rating.
Watch: Large adverse reserve strengthening, mortality or policyholder behavior shifts that force recurring non-cash charges or cash strain (would show up in MD&A/reserve roll-forwards before cash reverses).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
NetCashProvidedByUsedInOperatingActivities = 259000000.0 (annual, period_end 2025) — turned positive in 2025 after prior negatives.
Open source ↗The revenue jump in 2025 largely reflects realized investment gains / one-time capital transactions rather than a durable increase in recurring underwriting or fee-based margins.HoldingMateriality: High
Revenues = 6766000000.0 (annual, period_end 2025) versus 4724000000.0 (annual, period_end 2024) — a large year-over-year jump. If revenue growth is mainly one-off, future top-line and margin weakness will follow and current earnings may not repeat; if it’s recurring, the firm has a path to sustainably higher earnings.
Watch: MD&A or notes show the 2025 revenue increase came from recurring fee income growth and improved underwriting spreads (would indicate repeatability).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Revenues = 6766000000.0 (annual, period_end 2025) versus 4724000000.0 (annual, period_end 2024) — a large year-over-year jump.
Open source ↗Brighthouse’s cash and equity build in 2024–25 provide the capacity to fund buybacks or dividends if regulatory capital tests remain comfortable.StrengtheningMateriality: Medium
CashCashEquivalents... = 5387000000.0 (instant, period_end 2025) — cash increased versus prior years. A commitment and ability to return capital would be the direct mechanism that turns improved results into shareholder value; lacking that, earnings improvements may not translate to a higher multiple.
Watch: Regulatory capital requirements or rating-agency demands that force retention of capital (would show via regulatory filings or management statements).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
CashCashEquivalents... = 5387000000.0 (instant, period_end 2025) — cash increased versus prior years.
Open source ↗Brighthouse’s EPS and earnings will remain materially cyclical and sensitive to investment markets and reserve activity unless product mix shifts meaningfully toward fee-based, lower-guarantee products.StrengtheningMateriality: Medium
EarningsPerShareDiluted swung from -18.39 (annual, 2023) to 4.64 (annual, 2024) to 5.71 (annual, 2025), with 51.3 in 2022 — illustrating large year-to-year volatility. Persistent cyclicality implies higher volatility in dividends and valuation; a clear, durable shift in product mix would lower volatility and support higher multiples.
Watch: Sustained sales and disclosed pipeline showing growth in fee-based annuity products and lower guaranteed liabilities (would appear in sales distribution/MD&A disclosures).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
EarningsPerShareDiluted swung from -18.39 (annual, 2023) to 4.64 (annual, 2024) to 5.71 (annual, 2025), with 51.3 in 2022 — illustrating.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Improved liability management and capital-recycling actions will convert Brighthouse’s reported profits into sustainable positive operating cash flow, enabling recurring shareholder distributions. If true, owners get a growing, reliable cash return (buybacks/dividends) and valuation expansion; if false, profits may not convert to distributable cash and the stock will be vulnerable to re-rating.
The revenue jump in 2025 largely reflects realized investment gains / one-time capital transactions rather than a durable increase in recurring underwriting or fee-based margins. If revenue growth is mainly one-off, future top-line and margin weakness will follow and current earnings may not repeat; if it’s recurring, the firm has a path to sustainably higher earnings.
Brighthouse’s cash and equity build in 2024–25 provide the capacity to fund buybacks or dividends if regulatory capital tests remain comfortable. A commitment and ability to return capital would be the direct mechanism that turns improved results into shareholder value; lacking that, earnings improvements may not translate to a higher multiple.
Brighthouse’s EPS and earnings will remain materially cyclical and sensitive to investment markets and reserve activity unless product mix shifts meaningfully toward fee-based, lower-guarantee products. Persistent cyclicality implies higher volatility in dividends and valuation; a clear, durable shift in product mix would lower volatility and support higher multiples.
All standing thesis claims
Original report summary
the 2024–25 improvement in earnings and cash proves durable rather than one-off.
Bull case and bear case
Bull case and bear case for Brighthouse Financial
Where the evidence on Brighthouse Financial stands: Holding on the latest evidence (Nov 6, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.
Bull case: what the evidence supports
Improved liability management and capital-recycling actions will convert Brighthouse’s reported profits into sustainable positive operating cash flow, enabling recurring shareholder distributions.
The revenue jump in 2025 largely reflects realized investment gains / one-time capital transactions rather than a durable increase in recurring underwriting or fee-based margins.
Brighthouse’s cash and equity build in 2024–25 provide the capacity to fund buybacks or dividends if regulatory capital tests remain comfortable.
Brighthouse’s EPS and earnings will remain materially cyclical and sensitive to investment markets and reserve activity unless product mix shifts meaningfully toward fee-based, lower-guarantee products.
Bear case: what would count against it
Large adverse reserve strengthening, mortality or policyholder behavior shifts that force recurring non-cash charges or cash strain (would show up in MD&A/reserve roll-forwards before cash reverses).
MD&A or notes show the 2025 revenue increase came from recurring fee income growth and improved underwriting spreads (would indicate repeatability).
Regulatory capital requirements or rating-agency demands that force retention of capital (would show via regulatory filings or management statements).
Thesis-Break Engine
Thesis-break watch · Brighthouse Financial
OptimistFi is watching Brighthouse Financial. No break-condition checks are on record yet — they accumulate as new filings are checked.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
Brighthouse Financial filed an SEC 8-K on 2026-11-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
Brighthouse Financial filed an SEC 8-K on 2026-08-18: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Brighthouse Financial filed an SEC 8-K on 2026-08-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Large adverse reserve strengthening, mortality or policyholder behavior shifts that force recurring non-cash charges or cash strain (would show up in MD&A/reserve roll-forwards before cash reverses).
- MD&A or notes show the 2025 revenue increase came from recurring fee income growth and improved underwriting spreads (would indicate repeatability).
- Regulatory capital requirements or rating-agency demands that force retention of capital (would show via regulatory filings or management statements).
- Sustained sales and disclosed pipeline showing growth in fee-based annuity products and lower guaranteed liabilities (would appear in sales distribution/MD&A disclosures).
BHF news
Loading headlines…
Financial statements
BHF income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
BHF: quick answers
- When does Brighthouse Financial (BHF) report earnings next?
- Brighthouse Financial's next results are projected for February 22, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 5, 2026. Earnings calendar
- What is BHF's short interest?
- As of October 30, 2026, 6.7M BHF shares were sold short, 11.7% of its shares outstanding, down 1.7% from the count before. At the stock's average daily volume that is 8.8 days to cover. FINRA publishes the count twice a month. BHF short interest history
- Have members of Congress traded BHF?
- 11 trades in BHF have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed BHF trade
- Which well-known investors own BHF?
- 1 of the 37 well-known funds tracked here reported BHF shares in their latest 13F filing. By share of the fund's portfolio: Soros Fund Management (George Soros), 0.9%. Fund portfolios
BHF in well-known investors’ portfolios
1 of 37 funds reported BHF shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| George SorosSoros Fund Management | 0.87% | $70.7M | +31.8% | Q2 2026 |
